SCM
DRNA
Silverarc Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-31,040
| Closed | -$626K | – | 93 |
|
|
2021
Q3 | $626K | Sell |
31,040
-198,852
| -86% | -$4.01M | 0.35% | 61 |
|
|
2021
Q2 | $8.58K | Buy |
229,892
+29,892
| +15% | +$1.12K | 3.83% | 2 |
|
|
2021
Q1 | $5.11M | Sell |
200,000
-27,388
| -12% | -$700K | 2.79% | 8 |
|
|
2020
Q4 | $5.01M | Buy |
+227,388
| New | +$5.01M | 2.91% | 6 |
|